Sana Biotechnology, which had planned to produce drugs in-house, will instead turn to CDMOs for manufacturing and pause the ...

As it continues development of its rademikibart for asthma and other inflammatory diseases, Connect Biopharma is teaming up ...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...

The National Advertising Division (NAD) has sided with Genomic Health in a challenge the Exact Sciences subsidiary brought ...

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

With a landmark U.S. approval  Tuesday, Insmed is making waves with a new class of drug that’s also the first to be green lit ...

Days after President Donald Trump called on drugmakers to offer direct-to-consumer distribution of their products in the U.S.

VML Health has stepped up its work on advanced technology, data and artificial-intelligence-enabled strategies by naming ...

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

Texas Attorney General Ken Paxton and Health Choice Alliance are accusing Eli Lilly of “incentivizing” providers in the state ...